Sunresin's life sciences team is attending the OLIGONUCLEOTIDE THERAPEUTICS 2024:
hub-xchange.com/oligonucleot… on San Diego, on the 28 February.
Alessandra Basso will give the Opening Address & Keynote Presentation for the day with the title “Overview of the oligonucleotide market expansion. How to support the supply chain with cost-effective and reliable resins for solid phase synthesis” The presentation will address how the resin for solid phase synthesis is a major cost contribution factor in the cost of final oligonucleotides and how Sunresin is overcomeing this.
A new range of resins has been developed to support the requirements of the expanding oligo applications, with uality and reproducibility as a key factor in the oligo final purity and yield.
In addition we will be present with a poster session, where you can discuss face by face with Alessandra Basso, Fred Ghanem, Ph.D. and Yaping Hou
We look forward to seeing you in San Diego!
#Sunresin #lifesciences #OLIGONUCLEOTIDETHERAPEUTICS2024 #oligonucleotide #solidphasesynthesis